The viability test of sappan wood (Caesalpinia sappan L.) ethanol extract in the H9C2 cell line

2Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Objective: In this study, the embryonic rat cardiomyocyte cell line H9C2 was used to investigate the cardiotoxicity effect of sappan wood ethanol extract (SWEE). Methods: Sappan wood was extracted in 96% ethanol and divided into dose concentrations of 2.5, 5, 10, 50, 100, and 150 µg/ml, with deferiprone used as a control. Cell viability was assessed using the PrestoBlue Cell Viability Reagent, according to manufacturer protocols. Results: Microscopic examination showed that the cell viability of H9C2 was preserved by SWEE treatments at a dose of 10 µg/ml and suggested dose concentrations of 50 µg/ml of SWEE. The percentage of viable cells was greater than 95% with a dose concentration of 10 µg/ml of SWEE, but it was significantly reduced with a dose concentration of 50 µg/ml of SWEE (p<0.05). Conclusion: The optimal dose concentration of SWEE to reach 95% cell viability was 10 µg/ml.

Cite

CITATION STYLE

APA

Sulistiyorini, I., Safitri, R., Lesmana, R., & Syamsunarno, M. R. A. A. (2020). The viability test of sappan wood (Caesalpinia sappan L.) ethanol extract in the H9C2 cell line. International Journal of Applied Pharmaceutics, 12(Special Issue 3), 76–78. https://doi.org/10.22159/ijap.2020.v12s3.39479

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free